Yesterday, our colleague Lindsay attended the UK CA (MHRA) Regulatory Symposium 🇬🇧, where two major topics were in focus:
ICH GCP R3 Update – What’s changing and its impact on trials.
UK Clinical Trials Regulation – Moving forward in the House of Lords.
With regulatory frameworks evolving, staying informed is key. Events like this provide valuable insights and keep us prepared for what’s ahead.
Were you there as well? Let’s connect and exchange thoughts! 🤝